TABLE 2.
Number of: | Total | Ranitidine | No ranitidine | p‐value |
---|---|---|---|---|
Patients | 108 | 45 | 63 | |
Administrations | 836 | 349 | 487 | |
Hypersensitivity reactions per administration | 20 (2.4%) | 8 (2.3%) | 12 (2.5%) | .87 |
Patients with hypersensitivity reactions | 18 (16.7%) | 8 (17.8%) | 10 (15.8%) | .80 |